|

EMERGENT BIOSOLUTIONS INC (EBS)

US29089Q1058 - Common Stock

2.01  -0.06 (-2.9%)

After market: 2 -0.01 (-0.5%)

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.07B1.12B1.79B1.56B1.11B
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
713.70M693.70M716.00M506.70M433.50M
Gross Profit
360.00M427.20M1.08B1.05B672.50M
Operating Expenses
594.70M593.20M640.90M568.60M558.40M
Research and Development
163.40M193.00M234.00M205.50M226.20M
Selling, General, and Administrative Expenses
366.30M340.30M348.40M303.30M273.50M
Operating Income
-234.70M-166.00M435.80M480.10M114.10M
Interest Income/Expense
-67.80M-37.30M-34.50M-31.30M-38.40M
Other Income/Expense
-5.40M-11.70M-3.70M4.70M1.70M
Non Recurring Items
N/A-6.70M-83.20M-46.30MN/A
Income Before Taxes
-546.40M-221.70M314.40M407.20M77.40M
Income Tax
61.60M2.10M83.50M102.10M22.90M
Net Income
-608.00M-223.80M230.90M305.10M54.50M
EBITDA
-99.30M-22.70M559.60M594.60M224.80M
 
Per Share Data
EPS Diluted Total Ops
-12.08-4.474.275.671.04
Non GAAP EPS
-5.81-2.266.007.852.77
 
Statistics
Gross Profit Margin
33.53%38.11%60.06%67.42%60.80%
Profit Margin
-56.63%-19.97%12.88%19.62%4.93%
Operating Profit Margin
-21.86%-14.81%24.31%30.87%10.32%

All data in USD

Charts